OBJECTIVE: The major form of magnetic resonance imaging-defined white matter injury (WMI) comprises diffuse lesions where the burden of small necrotic foci (microscopic necrosis) is poorly defined. We hypothesized that myelination failure associated with diffuse WMI involves an aberrant injury response linked to arrested preoligodendrocyte (preOL) maturation in reactive astrocyte-rich lesions. METHODS: A retrospective autopsy series (1983-2000) was selected for cases with diffuse WMI and analyzed relative to prospectively collected contemporary cases (2003-2010). Controls were age- and region-matched to address regional variation in preOL maturation. Successive oligodendrocyte stages were analyzed with lineage-specific markers. Microscopic necrosis was quantified with microglial markers. Axon injury markers defined the burden of axonopathy. Extracellular matrix remodeling was defined by detection of hyaluronic acid (HA), an inhibitor of preOL maturation, and the HA receptor, CD44. RESULTS: In the contemporary case series, diffuse WMI was accompanied by a significant reduction in the burden of microscopic necrosis and axonopathy. Diffuse astrogliosis extended into the lesion surround with elevated HA and astrocyte-expressed CD44. The total population of OL lineage stages was significantly increased in lesions. This increase coincided with significant expansion of the preOL pool. INTERPRETATION: Although these data confirm that microscopic necrosis occurs in contemporary cases, the markedly decreased burden supports that it does not contribute substantially to myelination failure. The primary mechanism of myelination failure involves a disrupted cellular response whereby preOLs fail to differentiate in diffuse astrogliotic lesions. PreOL maturation arrest converts chronic WMI to a more immature state related to the burden of astrogliosis.
OBJECTIVE: The major form of magnetic resonance imaging-defined white matter injury (WMI) comprises diffuse lesions where the burden of small necrotic foci (microscopic necrosis) is poorly defined. We hypothesized that myelination failure associated with diffuse WMI involves an aberrant injury response linked to arrested preoligodendrocyte (preOL) maturation in reactive astrocyte-rich lesions. METHODS: A retrospective autopsy series (1983-2000) was selected for cases with diffuse WMI and analyzed relative to prospectively collected contemporary cases (2003-2010). Controls were age- and region-matched to address regional variation in preOL maturation. Successive oligodendrocyte stages were analyzed with lineage-specific markers. Microscopic necrosis was quantified with microglial markers. Axon injury markers defined the burden of axonopathy. Extracellular matrix remodeling was defined by detection of hyaluronic acid (HA), an inhibitor of preOL maturation, and the HA receptor, CD44. RESULTS: In the contemporary case series, diffuse WMI was accompanied by a significant reduction in the burden of microscopic necrosis and axonopathy. Diffuse astrogliosis extended into the lesion surround with elevated HA and astrocyte-expressed CD44. The total population of OL lineage stages was significantly increased in lesions. This increase coincided with significant expansion of the preOL pool. INTERPRETATION: Although these data confirm that microscopic necrosis occurs in contemporary cases, the markedly decreased burden supports that it does not contribute substantially to myelination failure. The primary mechanism of myelination failure involves a disrupted cellular response whereby preOLs fail to differentiate in diffuse astrogliotic lesions. PreOL maturation arrest converts chronic WMI to a more immature state related to the burden of astrogliosis.
Authors: A Hirayama; Y Okoshi; Y Hachiya; Y Ozawa; M Ito; Y Kida; Y Imai; S Kohsaka; S Takashima Journal: Clin Neuropathol Date: 2001 Mar-Apr Impact factor: 1.368
Authors: Stephen A Back; Therese M F Tuohy; Hanqin Chen; Nicholas Wallingford; Andrew Craig; Jaime Struve; Ning Ling Luo; Fatima Banine; Ying Liu; Ansi Chang; Bruce D Trapp; Bruce F Bebo; Mahendra S Rao; Larry S Sherman Journal: Nat Med Date: 2005-08-07 Impact factor: 53.440
Authors: Shannon E G Hamrick; Steven P Miller; Carol Leonard; David V Glidden; Ruth Goldstein; Vijay Ramaswamy; Robert Piecuch; Donna M Ferriero Journal: J Pediatr Date: 2004-11 Impact factor: 4.406
Authors: Stephen A Back; Ning Ling Luo; Natalia S Borenstein; Joseph J Volpe; Hannah C Kinney Journal: J Neuropathol Exp Neurol Date: 2002-02 Impact factor: 3.685
Authors: Therese M F Tuohy; Nicholas Wallingford; Ying Liu; Frank H Chan; Tilat Rizvi; Rubing Xing; Bruce Bebo; Mahendra S Rao; Larry S Sherman Journal: Glia Date: 2004-09 Impact factor: 7.452
Authors: Hannah C Glass; Sonia L Bonifacio; Vann Chau; David Glidden; Kenneth Poskitt; A James Barkovich; Donna M Ferriero; Steven P Miller Journal: Pediatrics Date: 2008-08 Impact factor: 7.124
Authors: Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan Journal: Nat Med Date: 2002-09-23 Impact factor: 53.440
Authors: Art Riddle; Jennifer Maire; Xi Gong; Kevin X Chen; Christopher D Kroenke; A Roger Hohimer; Stephen A Back Journal: Stroke Date: 2011-11-10 Impact factor: 7.914
Authors: Jingang Li; Tamara Yawno; Amy Sutherland; Jan Loose; Ilias Nitsos; Beth J Allison; Robert Bischof; Courtney A McDonald; Graham Jenkin; Suzanne L Miller Journal: Pediatr Res Date: 2017-08-16 Impact factor: 3.756
Authors: Justin M Dean; Evelyn McClendon; A Roger Hohimer; Christopher D Kroenke; Kelly Hansen; Aryan Azimi-Zonooz; Kevin Chen; Art Riddle; Xi Gong; Elica Sharifnia; Matthew Hagen; Tahir Ahmad; Lindsey A Leigland; Stephen A Back Journal: Sci Transl Med Date: 2013-01-16 Impact factor: 17.956
Authors: Vann Chau; Anne Synnes; Ruth E Grunau; Kenneth J Poskitt; Rollin Brant; Steven P Miller Journal: Neurology Date: 2013-11-08 Impact factor: 9.910